| Name | Title | Contact Details |
|---|
Ceterix Orthopaedics is singularly focused on meniscal preservation and is dedicated to providing patients every opportunity to maintain the natural health and stability of their knee. The company develops tools that help surgeons repair many of the tears that currently remain untreated or are treated by meniscectomy (meniscus removal), a procedure associated with increased risk of arthritis or total knee replacement later in life. The Ceterix NovoStitch® Plus Meniscal Repair System provides surgeons with the unique ability to repair horizontal, radial, root and other complex tears. Based in Fremont, Calif., the company is backed by investors Novo Ventures, Versant Ventures and 5AM Ventures.
Planmeca USA, a leading manufacturer of dental imaging and CAD/CAM equipment, recently moved its North American headquarters to a larger, high-tech facility that will house advanced training and facilitate innovation.
Post Surgical Manufacturing is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.
F2 Creations is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.